Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome.
Marie RoelensAdele de MassonAnais AndrillonCaroline Ram-WolffLucie BiardMarie BoissonSamia MourahMaxime BattistellaAntoine ToubertMartine BagotHélène Moins-TeisserencPublished in: The British journal of dermatology (2022)
SCs, not explained only by mutations within CCR4 coding regions.